Literature DB >> 17949692

The pharmacogenetics of major depression: past, present, and future.

Gonzalo Laje1, Francis J McMahon.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17949692     DOI： 10.1016/j.biopsych.2007.09.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  12 in total

1.  The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.

Authors:  David A Nielsen; Sara C Hamon; Thomas R Kosten
Journal:  Psychiatr Genet       Date:  2013-12       Impact factor: 2.458

2.  Pharmacogenetics of antidepressive treatment.

Authors:  Astrid Zobel; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-01-03       Impact factor: 5.270

Review 3.  Pharmacogenetics of major depression: insights from level 1 of the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial.

Authors:  Magnus Lekman; Silvia Paddock; Francis J McMahon
Journal:  Mol Diagn Ther       Date:  2008       Impact factor: 4.074

4.  A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.

Authors:  Chen Zhang; Zezhi Li; Zhiguo Wu; Jun Chen; Zuowei Wang; Daihui Peng; Wu Hong; Chengmei Yuan; Zhen Wang; Shunying Yu; Yifeng Xu; Lin Xu; Zeping Xiao; Yiru Fang
Journal:  Psychopharmacology (Berl)       Date:  2013-10-11       Impact factor: 4.530

5.  Baseline mood-state measures as predictors of antidepressant response to scopolamine.

Authors:  Maura L Furey; Allison C Nugent; Andrew M Speer; David A Luckenbaugh; Elana M Hoffman; Erica Frankel; Wayne C Drevets; Carlos A Zarate
Journal:  Psychiatry Res       Date:  2012-02-18       Impact factor: 3.222

6.  DBH gene as predictor of response in a cocaine vaccine clinical trial.

Authors:  Thomas R Kosten; Coreen B Domingo; Sara C Hamon; David A Nielsen
Journal:  Neurosci Lett       Date:  2013-02-28       Impact factor: 3.046

7.  Pharmacogenetic randomized trial for cocaine abuse: disulfiram and dopamine β-hydroxylase.

Authors:  Thomas R Kosten; Guiying Wu; Wen Huang; Mark J Harding; Sara C Hamon; Jaakko Lappalainen; David A Nielsen
Journal:  Biol Psychiatry       Date:  2012-08-18       Impact factor: 13.382

Review 8.  Biomarkers to predict antidepressant response.

Authors:  Andrew F Leuchter; Ian A Cook; Steven P Hamilton; Katherine L Narr; Arthur Toga; Aimee M Hunter; Kym Faull; Julian Whitelegge; Anne M Andrews; Joseph Loo; Baldwin Way; Stanley F Nelson; Steven Horvath; Barry D Lebowitz
Journal:  Curr Psychiatry Rep       Date:  2010-12       Impact factor: 5.285

9.  Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.

Authors:  Gonzalo Laje; Dara M Cannon; Andrew S Allen; Jackie M Klaver; Summer A Peck; Xinmin Liu; Husseini K Manji; Wayne C Drevets; Francis J McMahon
Journal:  Int J Neuropsychopharmacol       Date:  2010-01-05       Impact factor: 5.176

10.  The role of BDNF, NTRK2 gene and their interaction in development of treatment-resistant depression: data from multicenter, prospective, longitudinal clinic practice.

Authors:  Zezhi Li; Yanxia Zhang; Zuowei Wang; Jun Chen; Jinbo Fan; Yangtai Guan; Chen Zhang; Chengmei Yuan; Wu Hong; Yong Wang; Zhiguo Wu; Jia Huang; Yingyan Hu; Lan Cao; Zhenghui Yi; Donghong Cui; Shunying Yu; Yiru Fang
Journal:  J Psychiatr Res       Date:  2012-11-06       Impact factor: 4.791
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.